TREATMENT OF DEPRESSION ASSOCIATED WITH CEREBROVASCULAR DISEASE (ACCORDING TO THE DATA OF THE RESONANCE RUSSIAN MULTICENTER NATURALISTIC STUDY)
- 作者: Vorobyeva O.1
-
隶属关系:
- I.M. Sechenov First Moscow State Medical University
- 期: 卷 23, 编号 12 (2012)
- 页面: 26-29
- 栏目: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115549
- ID: 115549
如何引用文章
详细
Eighty-eight patients with depression and comorbid cerebrovascular disease were treated with Valdoxan (25-50 mg/day) in the Resonance Russian multicenter naturalistic study. Following 6-week therapy, depressive symptomatology was relieved in the vast majority (82.35%) of patients. 17-item Hamilton Depression Rating Scale (HAMD-17) scores decreased from 15.8±3.6 to 5.0±2.7 (p<0.00001). There was also a reduction in the intractable symptoms of depression (fatigability, low work efficiency, dyssomnia) and their negative impact on patient functioning.
全文:
作者简介
O. Vorobyeva
I.M. Sechenov First Moscow State Medical University
Email: oworobeva@mail.ru
Professor MD
参考
- Alexopoulos G., Meyers B., Young R. et al. Vasculardepression’ hypothesis // Arch. Gen. Psychiatry. - 1997; 54: 915-22.
- Krishnan K., Hays J., Blazer D. MRI-defined vascular depression // Am. J. Psychiatry. 1997; 154: 497-501.
- Navarro V., Gasto C., Lomena F. et al. Normalization of frontal cerebral perfusion in remitted elderly major depression: a 12-month follow-up SPECT study // Neuroimage. - 2002; 16: 781-7.
- Kusumi I., Koyama T., Yamashita I. Serotonin-stimulated Ca2+ response in increased in the blood platelets of depressed patients // Biol. Psychiatry. - 1991; 30: 310-2.
- Sapolsky R. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders // Arch. Gen. Psychiatry. - 2000; 57: 925-35.
- Jonathan W. Strong Tie Links Depression, Stroke, but What's Binding Them? // Psychiatric. News. - 2011; 46: 2-23.
- Everson S., Roberts R., Goldberg D. et al. Depressive symptoms and increased risk of stroke mortality over a 29-year period // Arch. Intern. Med. - 1998; 158: 1133-8.